Recently, the development of MMPIs has moved away from general MMPIs [181,182,183] towards specific inhibitors for MMP1 [184], gelatinases [185,186,187], MMP11 [188] and specific cancers [189] or stages of tumor progression [190]. This evidence concerns the gene MMP11 and neoplasm.